cyclohexanol has been researched along with Dysesthesia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angelo, LJ; Lee, KC | 1 |
| Durand, JP; Goldwasser, F | 1 |
| Brezault, C; Durand, JP; Goldwasser, F | 1 |
| Alexandre, J; Durand, JP; Goldwasser, F; Guillevin, L | 1 |
| Kowalski, T; Maier, C; Reinacher-Schick, A; Schlegel, U | 1 |
| Abbar, M; Blayac, JP; Giniès, E; Peyrière, H; Pinzani, V; Robert, L | 1 |
2 review(s) available for cyclohexanol and Dysesthesia
| Article | Year |
|---|---|
[Painful hyperexcitability syndrome with oxaliplatin containing chemotherapy. Clinical features, pathophysiology and therapeutic options].
Topics: Adrenergic Uptake Inhibitors; Amifostine; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Calcium Carbonate; Calcium Gluconate; Colorectal Neoplasms; Cyclohexanols; Humans; Hyperalgesia; Magnesium Chloride; Nerve Fibers; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Paresthesia; Peripheral Nerves; Rats; Selective Serotonin Reuptake Inhibitors; Sodium Channels; Venlafaxine Hydrochloride | 2008 |
[Venlafaxine withdrawal syndrome: report of six cases and review of the literature].
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Fatigue; Female; Gastrointestinal Diseases; Hallucinations; Headache; Humans; Male; Middle Aged; Paresthesia; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Time Factors; Venlafaxine Hydrochloride | 2000 |
4 other study(ies) available for cyclohexanol and Dysesthesia
| Article | Year |
|---|---|
Dose-related paresthesias with venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Humans; Male; Paresthesia; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2013 |
Dramatic recovery of paclitaxel-disabling neurosensory toxicity following treatment with venlafaxine.
Topics: Adenocarcinoma; Aged; Antidepressive Agents, Second-Generation; Antineoplastic Agents, Phytogenic; Cyclohexanols; Female; Humans; Neurotoxicity Syndromes; Ovarian Neoplasms; Paclitaxel; Paresthesia; Sensation Disorders; Venlafaxine Hydrochloride | 2002 |
Protection against oxaliplatin acute neurosensory toxicity by venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Antineoplastic Agents; Colonic Neoplasms; Cyclohexanols; Humans; Male; Organoplatinum Compounds; Oxaliplatin; Paresthesia; Venlafaxine Hydrochloride | 2003 |
Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cyclohexanols; Female; Fructose; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Paresthesia; Peripheral Nervous System Diseases; Recovery of Function; Topiramate; Venlafaxine Hydrochloride | 2005 |